Medical management of glaucoma: Moving on down the road
September 16th 2022Optometrists are seeing recent advances in topical therapies that entered the market following decades of reliance of traditional single-agent drops. An implantable device that facilitates the slow release of drug is changing the landscape in glaucoma therapy.
VEW 2022: New dark adaptation modality and other pipeline updates from Heru
September 15th 2022Brandon Barber, chief marketing officer at Heru, shares about the company's new dark adaptation modality, which they announced during the 2022 Vision Expo West, as well as other advancements in the pipeline.